Overview

Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis

Status:
Recruiting
Trial end date:
2021-01-30
Target enrollment:
Participant gender:
Summary
Psoriasis has been associated with an increasing risk for atherosclerosis. The investigators investigated whether surrogate markers of subclinical atherosclerosis, vascular dysfunction and myocardial dysfunction are impaired in patients with psoriasis compared to normal controls ,coronary artery disease patients and untreated hypertension subjects. The investigators also examined the effect of treatment with biological vs no biological agents on vascular and LV function in psoriasis.
Phase:
Phase 4
Details
Lead Sponsor:
University of Athens
Treatments:
Apremilast
Cyclosporine
Cyclosporins
Etanercept
Ustekinumab